Follow
Manuel Jurado
Manuel Jurado
Medico
Verified email at juntadeandalucia.es
Title
Cited by
Cited by
Year
Antilymphocyte globulin for prevention of chronic graft-versus-host disease
N Kröger, C Solano, C Wolschke, G Bandini, F Patriarca, M Pini, A Nagler, ...
New England Journal of Medicine 374 (1), 43-53, 2016
5242016
Dectin-1 and DC-SIGN polymorphisms associated with invasive pulmonary Aspergillosis infection
J Sainz, CB Lupiáñez, J Segura-Catena, L Vazquez, R Ríos, S Oyonarte, ...
PloS one 7 (2), e32273, 2012
1672012
Comparable survival between HIV+ and HIV non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation
JL Díez-Martín, P Balsalobre, A Re, M Michieli, JM Ribera, C Canals, ...
Blood, The Journal of the American Society of Hematology 113 (23), 6011-6014, 2009
1472009
Risk factors and outcome of COVID-19 in patients with hematological malignancies
JL Piñana, R Martino, I García-García, R Parody, MD Morales, G Benzo, ...
Experimental Hematology & Oncology 9, 1-16, 2020
1372020
IL1 gene cluster polymorphisms and its haplotypes may predict the risk to develop invasive pulmonary aspergillosis and modulate C-reactive protein level
J Sainz, E Perez, S Gomez-Lopera, M Jurado
Journal of clinical immunology 28, 473-485, 2008
1102008
Interleukin-10 promoter polymorphism as risk factor to develop invasive pulmonary aspergillosis
J Sainz, L Hassan, E Perez, A Romero, A Moratalla, E López-Fernández, ...
Immunology letters 109 (1), 76-82, 2007
1052007
Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections
C Sanz-Rodriguez, M Lopez-Duarte, M Jurado, J Lopez, R Arranz, ...
Bone marrow transplantation 34 (1), 13-20, 2004
1042004
Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium
R Ríos, CB Lupiañez, D Campa, A Martino, J Martínez-López, ...
Endocrine-related cancer 22 (4), 545-559, 2015
982015
Variable number of tandem repeats of TNF receptor type 2 promoter as genetic biomarker of susceptibility to develop invasive pulmonary aspergillosis
J Sainz, E Pérez, L Hassan, A Moratalla, A Romero, MD Collado, ...
Human immunology 68 (1), 41-50, 2007
972007
Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low …
M Jurado, HJ Deeg, B Storer, C Anasetti, JE Anderson, E Bryant, ...
Biology of blood and marrow transplantation 8 (3), 161-169, 2002
812002
Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease
M Jurado, C Vallejo, JA Pérez-Simón, S Brunet, C Ferra, P Balsalobre, ...
Biology of Blood and Marrow Transplantation 13 (6), 701-706, 2007
792007
TNFR1 mRNA expression level and TNFR1 gene polymorphisms are predictive markers for susceptibility to develop invasive pulmonary aspergillosis
J Sainz, I Salas-Alvarado, E Lopez-Fernandez, C Olmedo, A Comino, ...
International journal of immunopathology and pharmacology 23 (2), 423-436, 2010
762010
Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study
M Jurado, C De La Mata, A Ruiz-García, E López-Fernández, O Espinosa, ...
Cytotherapy 19 (8), 927-936, 2017
752017
Mechanisms that contribute to a profound reduction of the HIV-1 reservoir after allogeneic stem cell transplant
M Salgado, M Kwon, C Gálvez, J Badiola, M Nijhuis, A Bandera, ...
Annals of internal medicine 169 (10), 674-683, 2018
742018
Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique
A Urbano-Ispizua, C Solano, S Brunet, J De la Rubia, J Odriozola, ...
Bone marrow transplantation 22 (6), 519-525, 1998
731998
Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease
C Bueno, M Roldan, E Anguita, D Romero-Moya, B Martín-Antonio, ...
haematologica 99 (7), 1168, 2014
642014
GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute leukaemia …
F Bonifazi, C Solano, C Wolschke, M Sessa, F Patriarca, F Zallio, A Nagler, ...
The Lancet Haematology 6 (2), e89-e99, 2019
582019
Electron microscopy reveals the presence of viruses in mouse embryonic fibroblasts but neither in human embryonic fibroblasts nor in human mesenchymal cells used for hESC …
F Cobo, JM Navarro, MI Herrera, A Vivo, D Porcel, C Hernandez, ...
Cloning and Stem Cells 10 (1), 65-74, 2008
562008
Outcome of second allogeneic hematopoietic cell transplantation after relapse of myeloid malignancies following allogeneic hematopoietic cell transplantation: a retrospective …
G Orti, J Sanz, A Bermudez, D Caballero, C Martinez, J Sierra, JRC Marin, ...
Biology of Blood and Marrow Transplantation 22 (3), 584-588, 2016
552016
Polymorphisms in host immunity-modulating genes and risk of invasive aspergillosis: results from the AspBIOmics consortium
CB Lupianez, LM Canet, A Carvalho, L Alcazar-Fuoli, J Springer, ...
Infection and immunity 84 (3), 643-657, 2016
492016
The system can't perform the operation now. Try again later.
Articles 1–20